Oliver Luxxe Assets LLC Bristol Myers Squibb CO Transaction History

Oliver Luxxe Assets LLC

$528 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $1 Million - $1.12 Million	-17,294 Reduced 26.87%	47,067 $2.73 Million
Q2 2023 Aug 01, 2023	BUY	$63.71 - $70.74 $21,661 - $24,051	340 Added 0.53%	64,361 $4.12 Million
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $105,595 - $119,769	1,607 Added 2.57%	64,021 $4.44 Million
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $62,316 - $73,791	910 Added 1.48%	62,414 $4.49 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $381 - $225,371	2,933 Added 5.01%	61,504 $4.37 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $778,195 - $857,065	10,716 Added 22.39%	58,571 $4.51 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $790,570 - $926,050	13,361 Added 38.73%	47,855 $2.83 Million
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $75,158 - $81,847	-1,214 Reduced 3.4%	34,494 $2.31 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $51,329 - $57,730	865 Added 2.48%	35,708 $2.25 Million
Q4 2020 Feb 04, 2021	SELL	$57.74 - $65.43 $883,133 - $1 Million	-15,295 Reduced 30.51%	34,843 $2.26 Million
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $79,885 - $88,523	1,391 Added 2.85%	50,138 $3.02 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $20,667 - $24,161	377 Added 0.78%	48,747 $2.87 Million
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $2.24 Million - $3.26 Million	48,370 New	48,370 $2.82 Million
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $1.77 Million - $2.11 Million	-39,170 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $286,465 - $371,476	5,875 Added 17.65%	39,170 $2.04 Million
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $1.84 Million - $2.07 Million	33,295 New	33,295 $2.08 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.

Account